CD209 and neoplasm: The induction of DC-SIGN-binding high-mannose glycans on tumor cells prior to the induction of apoptosis with bortezomib resulted in high-mannose expressing ApoEVs, which facilitate enhanced uptake by moDCs via DC-SIGN and enabled antigen-specific CD8+ T cell priming.